Originally published Tuesday, October 28, 2008 at 12:00 AM
Comments (0)
E-mail article
Print view
ZymoGenetics falls 29 percent after lupus trial is halted
ZymoGenetics shares fell 29 percent Monday after a trial of its drug to treat kidney disease in lupus patients was discontinued by partner Merck Serono because of high risk of infection.
Seattle Times business reporter
ZymoGenetics shares fell 29 percent Monday after a trial of its drug to treat kidney disease in lupus patients was discontinued by partner Merck Serono because of high risk of infection.
The Seattle biotechnology company said in a securities filing Monday that Merck had halted a midstage trial of atacicept in people with systemic lupus erythematosus. ZymoGenetics shares closed at $3.53, down $1.42.
The ZymoGenetics-developed drug began testing in December in combination with therapies that help suppress the immune system. ZymoGenetics says it was the presence of the other drugs — not atacicept — that caused the infection.
"We think it was the combination ... we haven't seen any signs of infections like this in any of the other trials," said spokeswoman Susan Specht.
This trial is done, but other trials are continuing: Atacicept trials for other ailments such as rheumatoid arthritis and multiple sclerosis are still ongoing, the company said.
ZymoGenetics handed off the development and worldwide rights for atacicept to Merck Serono in early September. It will receive milestone payments and royalties from sales once the product launches.
The trial's discontinuation could delay the drug's commercialization until 2014, as the safety concerns reduce the possibility of an accelerated review by the U.S. Food and Drug Administration, said Oppenheimer & Co. analyst Kevin DeGeeter in a report.
ZymoGenetics shares have suffered in recent months, as the market seemed disappointed with the slowly growing sales of Recothrom, a compound to control surgical bleeding, which in January became the company's first commercial launch.
Monday's announcement further damaged the stock, now a far cry from its 52-week high of $15.23.
"Until we get data, it's really going to weigh on the stock," said Paul Latta, an analyst with McAdams Wright Ragen.
The event is "unfortunate for ZymoGenetics and for lupus patients," said Latta said. "There hasn't been a new treatment for lupus in decades."
Ángel González: 206-515-5644 or agonzalez@seattletimes.com
Copyright © 2008 The Seattle Times Company
More Business & Technology headlines...
E-mail article
Print view Share:
Digg
Newsvine
![]()
CES 2009: Technology demand strong despite slowdown
Seattle-area home sales fall in Dec. to end a down year
UPDATE - 01:47 PM
CBO projects $1.2 trillion deficit for 2009
UPDATE - 01:17 PM
Stocks close sharply lower, weighed down by profit warnings, job outlook
UPDATE - 03:20 PM
Obama taps spending watchdog, eyes Social Security

Snoqualmie flooding
Early flooding in the Snoqualmie Valley from the Snoqualmie and Tolt Rivers.
AP's News Minute
All of today's news in one minute.
shopping

events for Wednesday, Jan. 7th
- Karan Dannenberg Winter Clearance Sale
- Asher Anson Denim Sale
- Oslo's A Men's Store After-Christmas...
editors' picks
More Shopping Guides- Mystery solved: Gov. Gregoire visiting troops in Iraq
- Kirkland's Jason Mesnick spills about "The Bachelor"
- Puyallup mom who attacked child molester with baseball bat pleads guilty to assault
- Steve Kelley | UW football is "a sleeping giant" and Nick Holt plans to inject adrenaline
- In court, nightclub shooting suspect regained right to gun
- Pelicans fall out of sky from Mexico to Ore.
- 11 gay bars get letters threatening ricin attacks
- Chew on this: We'll soon be able to grow replacement teeth
- Federal racketeering trial begins for Washington Hells Angels
- New UW defensive coordinator Nick Holt calls Huskies job an awesome opportunity
- Israeli forces bisect Gaza, surround biggest city
486 - Holt's contract released --- he's making a lot
281 - 11 gay bars get letters threatening ricin attacks
139 - 2009 starts...slowly
87 - A few more Holt notes
68 - UW football is "a sleeping giant" and Nick Holt plans to inject adrenaline
49 - Donatell to USC? More Wednesday morning links
44 - Tuesday night wrapup
44 - Budget deficit looms largest
42 - City never responded to Metro's request to plow routes, bus chief says
40
- 11 gay bars get letters threatening ricin attacks
- Chew on this: We'll soon be able to grow replacement teeth
- Happy Hour | A taste of Hawaii on Queen Anne at Genki Sushi
- Homemade version of Buffalo Chicken Wings saves on calories, not on taste
- Pelicans fall out of sky from Mexico to Ore.
- Eating certain foods together helps with nutrient absorption
- Mystery solved: Gov. Gregoire visiting troops in Iraq
- Change your life in 2009 with these 52 tips
- Washington state employee hiring freeze lifted
- Median home price in King County tops $400,000 again in December
